[Sequential percutaneous surgical treatment in a woman with severe aortic stenosis and hypertrophic obstructive

A Román1, J Pereira, F Calvo

  • 1Servicio de Anestesiología, Reanimación y Tratamiento del Dolor, Hospital Meioxeiro, Vigo-CHUVI. adriana.roman.fernandez@sergas.es

Insights

Severe aortic stenosis and hypertrophic obstructive cardiomyopathy significantly impair quality of life. Percutaneous interventions offer a viable alternative treatment for high-risk patients, improving symptoms and function.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe aortic stenosis and hypertrophic obstructive cardiomyopathy significantly reduce quality of life and functional capacity.
  • Conventional surgical correction is highly effective but not suitable for all patients, particularly those at high risk.
  • Percutaneous techniques have emerged as a less invasive alternative for high-risk patient populations.

Observation:

  • A case report details a patient with severe symptomatic aortic stenosis and hypertrophic obstructive cardiomyopathy with mitral regurgitation.
  • The patient underwent percutaneous aortic valve implantation followed by percutaneous septal ablation.
  • The postoperative recovery was prolonged, and the hospital stay was extended.

Findings:

  • Percutaneous aortic valve implantation and septal ablation can be performed in patients with complex cardiac conditions.
  • These minimally invasive procedures can address severe aortic stenosis and hypertrophic obstructive cardiomyopathy with mitral regurgitation.
  • Successful treatment, despite a slow recovery, demonstrates the potential of percutaneous approaches.

Implications:

  • Percutaneous interventions provide a crucial alternative for high-risk patients ineligible for conventional surgery.
  • These techniques offer symptomatic relief and improved functional capacity in challenging cardiac cases.
  • While effective, percutaneous procedures carry inherent risks that necessitate careful patient selection and management.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...